entity

drugs

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about drugs: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections

1Hypotheses

5Analyses

3Outgoing

1Incoming

0Experiments

5Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Small Molecule Drugs for Neurodegenerative Diseases

therapeutic · 898 words

Outgoing (3)

Target	Relation	Type	Str
retinal toxicity	causes	disease	0.90
retinal toxicity	can_induce	disease	0.80
neuroregeneration	activates	process	0.70

Incoming (1)

Source	Relation	Type	Str
35361905	have been explored to protect or restore	paper	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN	0.552	neuropharmacology	What determines blood-brain barrier pene

Mentioning Analyses (5)

Scientific analyses that reference this entity

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.634

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604

Do oligodendrocytes require DNA repair enhancement or inhibition for neuroprotec

neurodegeneration | 2026-04-11 | 0 hypotheses

Does SYK activation provide neuroprotection or exacerbate neuroinflammation in e

neurodegeneration | 2026-04-11 | 0 hypotheses

What evidence supports Cdk5 activation as THE primary cause of AD versus other e

neurodegeneration | 2026-04-10 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

The debate revealed fundamental uncertainty about whether enhancing TYROBP-SYK s

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The abstract claims Cdk5 activation is the primary cause of AD, contradicting th

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate revealed conflicting therapeutic approaches - enhancing DNA repair ve

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

The observation that salsalate and diflunisal decrease both AD and TBI incidence

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The abstract challenges the rationale for using microtubule-stabilizing drugs in

closed · Rounds: 4 · Score: 0.68 · 2026-04-15

Related Research

Hypotheses and analyses mentioning drugs in their description or question text

No additional research found